X-ZELL Company
Democratising cancer diagnostics by bringing digital single-cell analytics into routine cytology
Technology:
Biomarkers of Female Cancers
Industry:
Systemic
Headquarters:
Singapore, Central Region, Singapore
Founded Date:
2014-12-01
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
13
Total Funding:
$5,560,000.00
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018-05-01
Last Funding Type:
Seed
Register and Claim Ownership